Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fusco

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Archives of Toxicology|May 20, 2026
CpG-ODN/Coa-ASC16 nanostructured adjuvant platform as a safe and effective alternative in Bothrops diporus antivenom productionGisela L Lopez, David Hernández, Caroline R C Costa, et al.
Journal of Clinical Epidemiology|March 17, 2004
Disease progression in HIV-infected patients treated with stavudine vs. zidovudineAmy C Justice, Daniel S Stein, Gregory P Fusco, et al.
Journal of the International Association of Providers of AIDS Care|April 23, 2026
Incident Hypertension with Antiretroviral Therapy in the OPERA CohortGerald Pierone, Laurence Brunet, Jennifer S Fusco, et al.
Journal of the International AIDS Society|December 17, 2025
Comparable real-world effectiveness between switches to cabotegravir + rilpivirine long-acting or modern daily oral regimens in the United States: an OPERA cohort studyRicky K Hsu, Michael G Sension, Jennifer S Fusco, et al.
Infectious Diseases and Therapy|March 22, 2026
Antiretroviral Therapy Switching Among People with HIV in the United States is not Uncommon Despite Virologic Suppression: An OPERA Cohort StudyKaram Mounzer, Michael D Osterman, Laurence Brunet, et al.
Infectious Diseases and Therapy|November 15, 2023
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA CohortMichael G Sension, Laurence Brunet, Ricky K Hsu, et al.
AIDS (London, England)|September 19, 2025
Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis BDouglas T Dieterich, Laurence Brunet, Ricky K Hsu, et al.
Brain, Behavior, and Immunity|June 21, 2026
Ventral striatal neuroimmune signalling biases the expression of social memory in male miceM Rinaudo, S Autelitano, C D'Amelio, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 3, 2025
Evaluation of a nanostructured CpG-ODN/ascorbyl palmitate as a safe and effective adjuvant for anticrotalic PLA2 serumLuciano S Fusco, Gisela L Lopez, Franco Maslovski, et al.
Drug Delivery and Translational Research|May 5, 2026
Dual role of ascorbyl Palmitate as coagel and adjuvant in experimental antivenom developmentFranco M Maslovski, Sofía G Brignone, Bruno Barrientos, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Archives of Toxicology|May 20, 2026
CpG-ODN/Coa-ASC16 nanostructured adjuvant platform as a safe and effective alternative in Bothrops diporus antivenom productionGisela L Lopez, David Hernández, Caroline R C Costa, et al.
Journal of Clinical Epidemiology|March 17, 2004
Disease progression in HIV-infected patients treated with stavudine vs. zidovudineAmy C Justice, Daniel S Stein, Gregory P Fusco, et al.
Journal of the International Association of Providers of AIDS Care|April 23, 2026
Incident Hypertension with Antiretroviral Therapy in the OPERA CohortGerald Pierone, Laurence Brunet, Jennifer S Fusco, et al.
Journal of the International AIDS Society|December 17, 2025
Comparable real-world effectiveness between switches to cabotegravir + rilpivirine long-acting or modern daily oral regimens in the United States: an OPERA cohort studyRicky K Hsu, Michael G Sension, Jennifer S Fusco, et al.
Infectious Diseases and Therapy|March 22, 2026
Antiretroviral Therapy Switching Among People with HIV in the United States is not Uncommon Despite Virologic Suppression: An OPERA Cohort StudyKaram Mounzer, Michael D Osterman, Laurence Brunet, et al.
Infectious Diseases and Therapy|November 15, 2023
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA CohortMichael G Sension, Laurence Brunet, Ricky K Hsu, et al.
AIDS (London, England)|September 19, 2025
Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis BDouglas T Dieterich, Laurence Brunet, Ricky K Hsu, et al.
Brain, Behavior, and Immunity|June 21, 2026
Ventral striatal neuroimmune signalling biases the expression of social memory in male miceM Rinaudo, S Autelitano, C D'Amelio, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 3, 2025
Evaluation of a nanostructured CpG-ODN/ascorbyl palmitate as a safe and effective adjuvant for anticrotalic PLA2 serumLuciano S Fusco, Gisela L Lopez, Franco Maslovski, et al.
Drug Delivery and Translational Research|May 5, 2026
Dual role of ascorbyl Palmitate as coagel and adjuvant in experimental antivenom developmentFranco M Maslovski, Sofía G Brignone, Bruno Barrientos, et al.
Pageof 8